Willcox, Abby
Culliford, Lucy
Ellis, Lucy
Rogers, Chris A
Cree, Angela http://orcid.org/0000-0002-1987-8900
Chakravarthy, Usha
Ennis, Sarah
Behar-Cohen, Francine
Reeves, Barnaby C http://orcid.org/0000-0002-5101-9487
Sivaprasad, Sobha http://orcid.org/0000-0001-8952-0659
Lotery, Andrew http://orcid.org/0000-0001-5541-4305
Article History
Received: 6 April 2018
Revised: 10 August 2018
Accepted: 22 August 2018
First Online: 7 September 2018
Compliance with ethical standards
:
: AW, LC, LE, CAR, AC, SE and BCR have no conflicts of interest. FB-C is an inventor on a patent protecting the use of MR antagonists in CSCR. SS has received research grants, travel grants, and speaker fees from Novartis, Bayer, Allergan, Roche, Heidelberg Engineering, and Optos. AL has received travel grants and speaker fees from Bayer and Roche.
: The views expressed in this publication are those of the author(s) and not necessarily those of the MRC, NHS, NIHR or the Department of Health.